Ligand validation:4DHL

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4DHL_EDO_A_507	81%	76%	0.094	0.946	0.52	0.41	-	-	0	0	100%	1
4DHL_EDO_D_506	79%	76%	0.103	0.95	0.54	0.39	-	-	0	0	100%	1
4DHL_EDO_D_507	60%	81%	0.155	0.941	0.5	0.32	-	-	1	0	100%	1
4DHL_EDO_D_508	48%	83%	0.142	0.884	0.59	0.19	-	-	1	0	100%	1
4DHL_EDO_D_511	48%	84%	0.207	0.951	0.5	0.26	-	-	0	0	100%	1
4DHL_EDO_D_510	36%	83%	0.176	0.868	0.55	0.23	-	-	2	0	100%	1
6OF5_EDO_A_524	70%	73%	0.118	0.937	0.72	0.32	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.